Relay Therapeutics, Inc. (RLAY)
8.92
+0.77
(+9.45%)
USD |
NASDAQ |
Feb 06, 16:00
8.88
-0.04
(-0.45%)
After-Hours: 20:00
Relay Therapeutics EPS Diluted (Quarterly) : -0.4301 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.390 |
| Celcuity, Inc. | -0.9204 |
| Theravance Biopharma, Inc. | 0.0696 |
| Prelude Therapeutics, Inc. | -0.2591 |
| Immunome, Inc. | -0.6532 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.15M |
| Total Expenses (Quarterly) | 74.15M |
| Enterprise Value | 982.93M |
| Earnings Yield | -19.63% |
| Normalized Earnings Yield | -19.63 |